June 7, 2021 -- Moderna and Medison Pharma announced that they are entering into a marketing agreement for Moderna's COVID-19 vaccine across central Europe and Israel.
The commercialization agreement will apply to about 20 countries in central and Eastern Europe.
Financial details of the agreement were not disclosed.
In other Moderna news, the company has filed for Health Canada authorization for the use of its COVID-19 vaccine in adolescents ages 12 to 18; it has also applied for conditional marketing approval of the vaccine for this age group in the European Union.